Skip to main content
. 2023 Feb 16;20(4):3451. doi: 10.3390/ijerph20043451

Table 2.

Rates of Total Examined Patients and Screening Exams (Retinopathy−).

Year(s) All Patients Total Examined Patients Rate of Total Examined Patients Screening Exams (Retinopathy−) Rate of Screening Exams (Retinopathy−) *
3/2017–3/2018 696 189 27.2% 94 16.4%
3/2018–3/2019 699 199 28.4% 99 17.4%
3/2019–3/2020 691 234 33.9% 122 22.1%
3/2020–9/2020 512 37 7.2% 13 2.8%
9/2020–3/2021 493 99 20.0% 44 10.6%

All Patients: Total SCD patients seen by a physician during the timeframe. Total Examined Patients: SCD patients who had an eye exam during the timeframe. Rate of Total Examined Patients: Rate of SCD patients with an eye exam, Total Examined Patients/All Patients. Screening exams: Number of SCD patients without a previous diagnosis of retinopathy (Retinopathy−) who had a (screening) eye exam during the timeframe. Rate of screening exams: a rate of screened patients among SCD patients without a previous diagnosis of retinopathy (Retinopathy−). * Rate of screening exams was calculated as follows: (Retinopathy− with screening exams)/(All Patients − (retinopathic patients)) = (Retinopathy− with screening exams)/(All Patients − (SCD patients not seen by a Montefiore ophthalmologist but with retinopathy noted in EMR + (Retinopathy+))).